Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12AstraZeneca

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BENRALIZUMAB

Brand Name : FASENRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML

Packaging :

Approval Date :

Application Number : 761070

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Benralizumab

Brand Name : Fasenra

Dosage Form : Inj Solution

Dosage Strength : 30mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Benralizumab

Brand Name : Fasenra Pen

Dosage Form : Inj L?s

Dosage Strength : 30mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BENRALIZUMAB

Brand Name : FASENRA PEN

Dosage Form : SOLUTION

Dosage Strength : 30MG/ML

Packaging :

Approval Date :

Application Number : 2496135

Regulatory Info : Prescription

Registration Country : Canada

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BENRALIZUMAB

Brand Name : FASENRA

Dosage Form : SOLUTION

Dosage Strength : 30MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2473232

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Benralizumab

Brand Name : Fasenra 30 mg

Dosage Form : PFP

Dosage Strength : 30mg/ml

Packaging : 1X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

benralizumab

Brand Name : Fasenra Pen

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank